Inventor · disambiguated record
Yihong Yao
Also filed as: YAO YIHONG
20 granted patents·36 pending applications·87 citations·filing 2003–2025
94Inventor score
Files withMEDIMMUNE LLC19CELLULAR BIOMEDICINE GROUP INC9ABELZETA INC7CELLULAR BIOMEDICINE GROUP HK LTD7SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD4
Top patents by PatentIndex Score
56 records- 0196US11472858B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Oct 18, 2022·7 cites·4 claims
- 0296US11439665B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Sep 13, 2022·8 cites·4 claims
- 0395US11633430B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 25, 2023·7 cites·5 claims
- 0495US11618778B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 4, 2023·7 cites·6 claims
- 0595US11608369B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Mar 21, 2023·7 cites·6 claims
- 0695US11207349B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Granted Dec 28, 2021·7 cites·5 claims
- 0794US11066457B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Granted Jul 20, 2021·8 cites·8 claims
- 0893US12311022B2Bispecific chimeric antigen receptors targeting CD20 and BCMAABELZETA INC·Filed 2024·Granted May 27, 2025·2 cites·6 claims
- 0992US12458667B2Bispecific chimeric antigen receptors targeting CD20 and BCMAABELZETA INC·Filed 2024·Granted Nov 4, 2025·1 cites·4 claims
- 1090US12448432B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofABELZETA INC·Filed 2022·Granted Oct 21, 2025·1 cites·10 claims
- 1188US11498973B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Nov 15, 2022·1 cites·4 claims
- 1287US9193789B2Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseCOYLE ANTHONY·Filed 2012·Granted Nov 24, 2015·16 cites·20 claims
- 1385US2025136707A1Bispecific chimeric antigen receptors targeting cd20 and bcmaABELZETA INC·Filed 2024·Application pending·0 cites
- 1484US9493570B2Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodiesMEDIMMUNE LLC·Filed 2013·Granted Nov 15, 2016·8 cites·1 claims
- 1582US11142581B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Granted Oct 12, 2021·1 cites·7 claims
- 1681US2023242613A1Construction of chimeric antigen receptor targeting cd20 antigen and activity identification of engineered t cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 1781US2024139243A1Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 1878US2025262243A1Bispecific chimeric antigen receptors targeting cd20 and bcmaABELZETA INC·Filed 2025·Application pending·0 cites
- 1972US12338494B2Reagent and method for fluorescence quantitative real-time PCR detection of RCLABELZETA INC·Filed 2023·Granted Jun 24, 2025·0 cites·7 claims
- 2070US10775388B2Methods of using antibodies to determine periostin levels in a sampleMEDIMMUNE LLC·Filed 2015·Granted Sep 15, 2020·1 cites·23 claims
- 2167US2023053305A1BCMA-Targeted Chimeric Antigen Receptor as well as Preparation Method Therefor and Application ThereofSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2022·Application pending·0 cites
- 2264US11697848B2Reagent and method for fluorescence quantitative real-time PCR detection of RCLCELLULAR BIOMEDICINE GROUP INC·Filed 2019·Granted Jul 11, 2023·0 cites·7 claims
- 2364US6945673B2Decorative illuminationsYAO YIHONG·Filed 2003·Granted Sep 20, 2005·5 cites·8 claims
- 2462US2010143372A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2007·Application pending·0 cites
- 2561US2015044222A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 2660US2025144215A1Method for enriching tumor infiltrating lymphocytesABELZETA INC·Filed 2023·Application pending·0 cites
- 2760US2008279851A1Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 2857US2024115605A1Chimeric antigen receptors targeting cd20CELLULAR BIOMEDICINE GROUP INC·Filed 2022·Application pending·0 cites
- 2956US2010261172A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 3056US2017121771A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 3155US9862762B2Monoclonal antibodies which bind human periostinMEDIMMUNE LLC·Filed 2015·Granted Jan 9, 2018·0 cites·18 claims
- 3255US2018179272A1Novel assay to detect human periostinMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 3353US2023212255A1Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 3453US2015132313A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 3551US2015147336A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3651US2024000839A1Bcma-targeted chimeric antigen receptorsSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2021·Application pending·0 cites
- 3750US2023104705A1Combined chimeric antigen receptor targeting cd19 and cd20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2020·Application pending·0 cites
- 3849US2023181640A1Anti-bcma antibodies and chimeric antigen receptorsSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2021·Application pending·0 cites
- 3949US2023144447A1Cd22-targeted chimeric antigen receptor, preparation method therefor and application thereofSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2021·Application pending·0 cites
- 4049US2011243929A1Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 4149US2022380726A1Universal car-t cell and preparation and use thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Application pending·0 cites
- 4248US2011262928A1Disease markers and uses thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 4348US2015252431A1Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapyMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 4448US2017088628A1Compositions and Methods for Identifying B Cell Malignancies Responsive to B Cell Depleting TherapyMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 4546US2016024205A1Type I Interferon DiagnosticMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 4645US2011287022A1Interferon alpha-induced pharmacodynamic markersYAO YIHONG·Filed 2009·Application pending·0 cites
- 4745US2012251546A1Type 1 inteferon diagnosticHIGGS BRANDON·Filed 2010·Application pending·0 cites
- 4844US2015191788A1Type 1 interferon diagnosticMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 4940US2005036298A1Soft plastic iridescent illuminationsFiled 2003·Application pending·0 cites
- 5039US2017275347A1Methods for identifying patients responsive to anti-pd-l1 antibody therapyMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yihong Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →